Showing results (1401-1410 of 1,427) with videos related to
Sort By:
Pageof 143
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
Novel set of plasma proteins classifies Alzheimer's dementia in African American individuals with high accuracyLindsey A Kuchenbecker, Kevin J Thompson, Cheyenne D Hurst, et al.Journal of Diabetes Investigation|April 27, 2024
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes EducatorsFeng-Chih Shen, Chih-Hsun Chu, Jung-Fu Chen, et al.Chinese Medical Journal|December 5, 2018
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER StudyWei Qiu, De-Hui Huang, Shi-Fang Hou, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setupPratik Devasthale, Wei Wang, Andres S Hernandez, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2025
Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's riskYen-Ning Huang, Shiwei Liu, Tamina Park, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 8, 2024
Association of amyloid and cardiovascular risk with cognition: Findings from KBASESoumilee Chaudhuri, Desarae A Dempsey, Yen-Ning Huang, et al.Bioorganic & Medicinal Chemistry Letters|September 21, 2015
Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studiesPratik Devasthale, Wei Wang, James Mignone, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 12, 2023
Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1Qing Zhong, Hua-Gen Wang, Ji-Hong Yang, et al.Journal of Oncology|May 17, 2019
Development and External Validation of Web-Based Models to Predict the Prognosis of Remnant Gastric Cancer after Surgery: A Multicenter StudyQi-Yue Chen, Qing Zhong, Jun-Feng Zhou, et al.Pageof 143